keyword
MENU ▼
Read by QxMD icon Read
search

lipid profile in liver cirrhosis

keyword
https://www.readbyqxmd.com/read/27895393/emerging-role-of-obeticholic-acid-in-the-management-of-nonalcoholic-fatty-liver-disease
#1
EDITORIAL
Evangelia Makri, Evangelos Cholongitas, Konstantinos Tziomalos
Nonalcoholic fatty liver disease (NAFLD) is the commonest chronic liver disease and its prevalence is increasing driven by the pandemic of obesity and type 2 diabetes mellitus. NAFLD can progress to cirrhosis and is associated with increased risk for cardiovascular disease and hepatocellular cancer. Diet and exercise are limited by suboptimal long-term adherence in patients with NAFLD. On the other hand, current pharmacological treatment of NAFLD has limited efficacy and unfavorable safety profile. In this context, obeticholic acid (OCA), a selective agonist of the farnesoid X receptors, might represent a useful option in these patients...
November 7, 2016: World Journal of Gastroenterology: WJG
https://www.readbyqxmd.com/read/27733832/silymarin-ameliorates-metabolic-dysfunction-associated-with-diet-induced-obesity-via-activation-of-farnesyl-x-receptor
#2
Ming Gu, Ping Zhao, Jinwen Huang, Yuanyuan Zhao, Yahui Wang, Yin Li, Yifei Li, Shengjie Fan, Yue-Ming Ma, Qingchun Tong, Li Yang, Guang Ji, Cheng Huang
Background and purpose: Silymarin, a standardized extract of the milk thistle seeds, has been widely used to treat chronic hepatitis, cirrhosis, and other types of toxic liver damage. Despite increasing studies on the action of silymarin and its major active constituent, silybin in their therapeutic properties against insulin resistance, diabetes and hyperlipidaemia in vitro and in vivo, the mechanism underlying silymarin action remains unclear. Experimental approach: C57BL/6 mice were fed high-fat diet (HFD) for 3 months to induce obesity, insulin resistance, hyperlipidaemia, and fatty liver...
2016: Frontiers in Pharmacology
https://www.readbyqxmd.com/read/27340749/clearance-of-hepatic-sphingomyelin-by-olipudase-alfa-is-associated-with-improvement-in-lipid-profiles-in-acid-sphingomyelinase-deficiency
#3
Beth L Thurberg, Melissa P Wasserstein, Simon A Jones, Thomas D Schiano, Gerald F Cox, Ana Cristina Puga
Acid sphingomyelinase deficiency (ASMD; Niemann-Pick disease type A and B) is a lysosomal storage disorder characterized by abnormal intracellular sphingomyelin (SM) accumulation. Prominent liver involvement results in hepatomegaly, fibrosis/cirrhosis, abnormal liver chemistries, and a proatherogenic lipid profile. Olipudase alfa (recombinant human ASM) is in clinical development as an investigational enzyme replacement therapy for the non-neurological manifestations of ASMD. In a phase 1b study conducted to evaluate the safety and tolerability of within-patient dose escalation with olipudase alfa, measurement of SM levels in liver biopsies was used as a pharmacodynamic biomarker of substrate burden...
September 2016: American Journal of Surgical Pathology
https://www.readbyqxmd.com/read/27311064/short-term-hypocaloric-high-fiber-and-high-protein-diet-improves-hepatic-steatosis-assessed-by-controlled-attenuation-parameter
#4
Anita Arslanow, Melanie Teutsch, Hardy Walle, Frank Grünhage, Frank Lammert, Caroline S Stokes
OBJECTIVES: Non-alcoholic fatty liver disease is one of the most prevalent liver diseases and increases the risk of fibrosis and cirrhosis. Current standard treatment focuses on lifestyle interventions. The primary aim of this study was to assess the effects of a short-term low-calorie diet on hepatic steatosis, using the controlled attenuation parameter (CAP) as quantitative tool. METHODS: In this prospective observational study, 60 patients with hepatic steatosis were monitored during a hypocaloric high-fiber, high-protein diet containing 1,000 kcal/day...
June 16, 2016: Clinical and Translational Gastroenterology
https://www.readbyqxmd.com/read/27123846/increased-circulating-levels-of-alpha-ketoglutarate-in-morbidly-obese-women-with-non-alcoholic-fatty-liver-disease
#5
Gemma Aragonès, Teresa Auguet, Alba Berlanga, Esther Guiu-Jurado, Salomé Martinez, Sandra Armengol, Fàtima Sabench, Rosa Ras, Mercè Hernandez, Carmen Aguilar, Josep Colom, Joan Josep Sirvent, Daniel Del Castillo, Cristóbal Richart
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) causes a wide spectrum of liver damage, ranging from simple steatosis to cirrhosis. However, simple steatosis (SS) and steatohepatitis (NASH) cannot yet be distinguished by clinical or laboratory features. The aim of this study was to assess the relationship between alpha-ketoglutarate and the degrees of NAFLD in morbidly obese patients. MATERIALS AND METHODS: We used a gas chromatography-quadruple time-of-flight-mass spectrometry analysis to quantify alpha-ketoglutarate in serum from normal-weight subjects (n = 30) and morbidly obese women (n = 97) with or without NAFLD...
2016: PloS One
https://www.readbyqxmd.com/read/27068811/plasma-lipid-profiling-of-different-types-of-hepatic-fibrosis-induced-by-carbon-tetrachloride-and-lomustine-in-rats
#6
Masaki Ishikawa, Kosuke Saito, Hiroshi Yamada, Noriyuki Nakatsu, Keiko Maekawa, Yoshiro Saito
BACKGROUND: Plasma lipid profiling has emerged as a useful tool for understanding the pathophysiology of hepatic injury and disease. Hepatic fibrosis results from chronic, progressive damage to the liver and can lead, in turn, to more serious conditions such as hepatic cirrhosis and hepatocellular carcinoma. Thus, the present study aimed to investigate the plasma lipid profiles of two types of hepatic fibrosis in order to aid the understanding of the pathophysiology of hepatic fibrosis...
2016: Lipids in Health and Disease
https://www.readbyqxmd.com/read/27020633/beneficial-effect-of-refined-red-palm-oil-on-lipid-peroxidation-and-monocyte-tissue-factor-in-hcv-related-liver-disease-a-randomized-controlled-study
#7
Roberto Catanzaro, Nicola Zerbinati, Umberto Solimene, Massimiliano Marcellino, Dheeraj Mohania, Angelo Italia, Antonio Ayala, Francesco Marotta
BACKGROUND: A large amount of endotoxin can be detected in the peripheral venous blood of patients with liver cirrhosis, contributing to the pathogenesis of hepatotoxicity because of its role in oxidative stress. The present study aimed to test the effect of the supplementation with red palm oil (RPO), which is a natural oil obtained from oil palm fruit (Elaeis guineensis) rich in natural fat-soluble tocopherols, tocotrienols and carotenoids, on lipid peroxidation and endotoxemia with plasma endotoxin-inactivating capacity, proinflammatory cytokines profile, and monocyte tissue factor in patients with chronic liver disease...
April 2016: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/26874844/a-micro-rna-expression-signature-for-human-nafld-progression
#8
Yan Guo, Yanhua Xiong, Quanghu Sheng, Shilin Zhao, Julia Wattacheril, Charles Robb Flynn
BACKGROUND: The spectrum of nonalcoholic fatty liver disease (NAFLD) describes disease conditions deteriorating from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) to cirrhosis (CIR) to hepatocellular carcinoma (HCC). From a molecular and biochemical perspective, our understanding of the etiology of this disease is limited by the broad spectrum of disease presentations, the lack of a thorough understanding of the factors contributing to disease susceptibility, and ethical concerns related to repeat sampling of the liver...
October 2016: Journal of Gastroenterology
https://www.readbyqxmd.com/read/26874076/elafibranor-an-agonist-of-the-peroxisome-proliferator-activated-receptor-%C3%AE-and%C3%A2-%C3%AE-induces-resolution-of-nonalcoholic-steatohepatitis-without-fibrosis-worsening
#9
Vlad Ratziu, Stephen A Harrison, Sven Francque, Pierre Bedossa, Philippe Lehert, Lawrence Serfaty, Manuel Romero-Gomez, Jérôme Boursier, Manal Abdelmalek, Steve Caldwell, Joost Drenth, Quentin M Anstee, Dean Hum, Remy Hanf, Alice Roudot, Sophie Megnien, Bart Staels, Arun Sanyal
BACKGROUND & AIMS: Elafibranor is an agonist of the peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-δ. Elafibranor improves insulin sensitivity, glucose homeostasis, and lipid metabolism and reduces inflammation. We assessed the safety and efficacy of elafibranor in an international, randomized, double-blind placebo-controlled trial of patients with nonalcoholic steatohepatitis (NASH). METHODS: Patients with NASH without cirrhosis were randomly assigned to groups given elafibranor 80 mg (n = 93), elafibranor 120 mg (n = 91), or placebo (n = 92) each day for 52 weeks at sites in Europe and the United States...
May 2016: Gastroenterology
https://www.readbyqxmd.com/read/26826811/counter-effects-of-n-sativa-l-and-p-ovate-l-on-indicative-markers-of-non-alcoholic-fatty-liver-disease
#10
Afshan Syed Abbas, Nadeem Sheikh
The broad spectrum of non-alcoholic fatty liver disease (NAFLD) diseases ranges from simple liver inflammation to steatosis, leading to fibrosis and cirrhosis. Four groups of weaning (30g) Rattus norvegicus were designated as W-0, W-I, W-II and W-III. For sixteen weeks group W-0 was given standard pallet diet, group I consumed diet "A" (20% fat Sucrose + 33% tea whitener + 34% ground pallet diet +13% water), group W-II was fed on diet "B" (50g Nigella sativa seeds/kg of A) and group W-III was provided with diet "C" (50g Plantago ovata husks /Kg of A)...
January 2016: Pakistan Journal of Pharmaceutical Sciences
https://www.readbyqxmd.com/read/26795831/multivariate-metabotyping-of-plasma-predicts-survival-in-patients-with-decompensated-cirrhosis
#11
Mark J W McPhail, Debbie L Shawcross, Matthew R Lewis, Iona Coltart, Elizabeth J Want, Charalambos G Antoniades, Kiril Veselkov, Evangelos Triantafyllou, Vishal Patel, Oltin Pop, Maria Gomez-Romero, Michael Kyriakides, Rabiya Zia, Robin D Abeles, Mary M E Crossey, Wayel Jassem, John O'Grady, Nigel Heaton, Georg Auzinger, William Bernal, Alberto Quaglia, Muireann Coen, Jeremy K Nicholson, Julia A Wendon, Elaine Holmes, Simon D Taylor-Robinson
BACKGROUND & AIMS: Predicting survival in decompensated cirrhosis (DC) is important in decision making for liver transplantation and resource allocation. We investigated whether high-resolution metabolic profiling can determine a metabolic phenotype associated with 90-day survival. METHODS: Two hundred and forty-eight subjects underwent plasma metabotyping by (1)H nuclear magnetic resonance (NMR) spectroscopy and reversed-phase ultra-performance liquid chromatography coupled to time-of-flight mass spectrometry (UPLC-TOF-MS; DC: 80-derivation set, 101-validation; stable cirrhosis (CLD) 20 and 47 healthy controls (HC))...
May 2016: Journal of Hepatology
https://www.readbyqxmd.com/read/26680993/serum-lipidomic-profiling-as-a-useful-tool-for-screening-potential-biomarkers-of-hepatitis-b-related-hepatocellular-carcinoma-by-ultraperformance-liquid-chromatography-mass-spectrometry
#12
Ana Maria Passos-Castilho, Valdemir Melechco Carvalho, Karina Helena Morais Cardozo, Luciana Kikuchi, Aline Lopes Chagas, Michele Soares Gomes-Gouvêa, Fernanda Malta, Ana Catharina de Seixas-Santos Nastri, João Renato Rebello Pinho, Flair José Carrilho, Celso Francisco Hernandes Granato
BACKGROUND: Chronic hepatitis B (CHB) virus infection is a major cause of hepatocellular carcinoma (HCC), as late diagnosis is the main factor for the poor survival of patients. There is an urgent need for accurate biomarkers for early diagnosis of HCC. The aim of the study was to explore the serum lipidome profiles of hepatitis B-related HCC to identify potential diagnostic biomarkers. METHODS: An ultraperformance liquid chromatography mass spectrometry (UPLC-MS) lipidomic method was used to characterize serum profiles from HCC (n = 32), liver cirrhosis (LC) (n = 30), CHB (n = 25), and healthy subjects (n = 34)...
2015: BMC Cancer
https://www.readbyqxmd.com/read/26580662/microrna-expression-relating-to-dietary-induced-liver-steatosis-and-nash
#13
REVIEW
Aida Zarfeshani, Sherry Ngo, Allan M Sheppard
Health issues associated with excessive caloric intake and sedentary lifestyle are driving a modern "epidemic" of liver disease. Initially presenting in the clinic as an excessive accumulation of fat within hepatocyte cells (steatosis), the progression to more severe non-alcoholic steatohepatitis (NASH) in which liver damage and inflammation are overt features, is becoming increasingly common. Often developing as a sequela of obesity, non-alcoholic fatty liver disease (NAFLD) arises in almost one-third of people initially carrying excess hepatic fat and is likely the result of the liver's limited capacity to cope with the modern-day levels of dietary fatty acids circulating in the blood...
2015: Journal of Clinical Medicine
https://www.readbyqxmd.com/read/26514502/resistin-and-insulin-resistance-a-link-between-inflammation-and-hepatocarcinogenesis
#14
Engy Yousry Elsayed, Nesreen Ahmed Mosalam, Noha Refaat Mohamed
BACKGROUND: Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third leading cause of cancer related death overall. The role of insulin resistance in the development of HCC associated with chronic HCV infection has not been established. Resistin is a polypeptide hormone belonging to the adipokine family which could contribute to tumorigenesis and angiogenesis. Our aim was to study serum resistin and insulin resistance as risk factors for HCC in HCV cirrhotic patients...
2015: Asian Pacific Journal of Cancer Prevention: APJCP
https://www.readbyqxmd.com/read/26486289/lipid-profile-of-cirrhotic-patients-and-its-association-with-prognostic-scores-a-cross-sectional-study
#15
Lílian Bassani, Sabrina Alves Fernandes, Fabiana Viegas Raimundo, Daniele Lazzarotto Harter, Maria Cristina Gonzalez, Cláudio Augusto Marroni
BACKGROUND: In cirrhosis the production of cholesterol and lipoproteins is altered. OBJECTIVE: Evaluate the lipid profile by measuring total cholesterol, very low-density lipoprotein, low-density lipoprotein, high-density lipoprotein and triglyceride levels in patients with cirrhosis caused by alcoholism and/or hepatitis C virus infection and determine its association with Child-Pugh and MELD scores. METHODS: Cross-sectional retrospective study of patients treated at the outpatient clinic in Porto Alegre, Brazil, from 2006 to 2010...
July 2015: Arquivos de Gastroenterologia
https://www.readbyqxmd.com/read/26448681/c57bl-6-and-a-j-mice-have-different-inflammatory-response-and-liver-lipid-profile-in-experimental-alcoholic-liver-disease
#16
Lorena Bavia, Íris Arantes de Castro, Lourdes Isaac
Alcoholic liver disease (ALD) is an important worldwide public health issue characterized by liver steatosis, inflammation, necrosis, and apoptosis of hepatocytes with eventual development of fibrosis and cirrhosis. Comparison of murine models with different inflammatory responses for ALD is important for an evaluation of the importance of genetic background in the interpretation of ethanol-induced phenotypes. Here, we investigated the role of inflammation and genetic background for the establishment of ALD using two different mouse strains: C57BL/6 (B6) and A/J...
2015: Mediators of Inflammation
https://www.readbyqxmd.com/read/26425466/profile-of-liver-enzymes-in-non-alcoholic-fatty-liver-disease-in-patients-with-impaired-glucose-tolerance-and-newly-detected-untreated-type-2-diabetes
#17
Debmalya Sanyal, Pradip Mukherjee, Moutusi Raychaudhuri, Sujoy Ghosh, Satinath Mukherjee, Subhankar Chowdhury
CONTEXT: The perception of non-alcoholic fatty liver disease (NAFLD) as an uncommon and benign condition is rapidly changing. Approximately, 70% type 2 diabetes mellitus (T2DM) patients have a fatty liver, which may follow an aggressive course with necroinflammation and fibrosis. AIMS: To assess the profile of liver enzymes in subjects with impaired glucose tolerance (IGT), new onset treatment naive T2DM and normal glucose tolerance (NGT) with and without NAFLD...
September 2015: Indian Journal of Endocrinology and Metabolism
https://www.readbyqxmd.com/read/26396524/new-advances-in-the-treatment-of-generalized-lipodystrophy-role-of-metreleptin
#18
REVIEW
Alexander J Rodriguez, Claudio A Mastronardi, Gilberto J Paz-Filho
Recombinant methionyl human leptin or metreleptin is a synthetic leptin analog that has been trialed in patients with leptin-deficient conditions, such as leptin deficiency due to mutations in the leptin gene, hypothalamic amenorrhea, and lipodystrophy syndromes. These syndromes are characterized by partial or complete absence of adipose tissue and hormones derived from adipose tissue, most importantly leptin. Patients deficient in leptin exhibit a number of severe metabolic abnormalities such as hyperglycemia, hypertriglyceridemia, and hepatic steatosis, which can progress to diabetes mellitus, acute pancreatitis, and hepatic cirrhosis, respectively...
2015: Therapeutics and Clinical Risk Management
https://www.readbyqxmd.com/read/26393179/chronic-liver-diseases-in-children-clinical-profile-and-histology
#19
Sachin Devidas Dhole, Archana S Kher, Radha G Ghildiyal, Manjusha P Tambse
AIM: The main aim of the study is to study the clinical profile of disorders of the liver and hepatobiliary system in paediatric patients and to correlate the histopathology findings of liver biopsy in chronic liver disease. Another aim being to assess the prognosis and to know the outcome and the effects of treatment in chronic liver diseases in paediatric age group. MATERIALS AND METHODS: It was a prospective study, included the clinical profile of Chronic Liver Diseases (CLD) in children and the histopathological correlation...
July 2015: Journal of Clinical and Diagnostic Research: JCDR
https://www.readbyqxmd.com/read/26355775/hepatocellular-carcinoma-in-non-alcoholic-fatty-liver-disease-epidemiology-pathogenesis-and-prevention
#20
REVIEW
György Baffy
Hepatocellular cancer (HCC) is the fifth most prevalent cancer worldwide and the third leading cause of cancer-related deaths. Non-alcoholic fatty liver disease (NAFLD), a spectrum of hepatic disorders associated with obesity and the metabolic syndrome, is a recognized risk factor for HCC. NAFLD that is advanced to cirrhosis carries the highest risk for HCC, but there is increasing concern that NAFLD-associated HCC may also occur in non-cirrhotic liver. As NAFLD is rapidly becoming the most common liver condition, it has been implicated in the worrisome trend of rising HCC incidence in a number of countries, which may offset successful measures in reducing the effect of virus-related liver cancer...
December 2013: Journal of Clinical and Translational Hepatology
keyword
keyword
118464
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"